Market Overview:
The global pulmonary devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of respiratory diseases, technological advancements in pulmonary devices, and rising demand for home-based care. Based on type, the global pulmonary devices market is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices. The therapeutic device segment accounted for the largest share of the global pulmonary device market in 2017 owing to the increasing use of these devices for treating respiratory diseases.
Product Definition:
Pulmonary devices are medical devices that are used to treat or prevent pulmonary diseases. Pulmonary devices include ventilators, oxygen tanks, and nebulizers. The use of pulmonary devices is important because they can help improve the quality of life for people with pulmonary diseases.
Therapeutic Devices:
Therapeutic devices are used to treat lung diseases and pulmonary disorders. The therapeutic devices market is expected to grow at a lucrative rate over the forecast period owing to increasing prevalence of chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and other pulmonary disorders. According to the World Health Organization (WHO) estimates in 2016, approximately 65 million people were suffering from COPD globally which is projected to rise substantially by 2030.
Consumables and Accessories:
Consumables and accessories are the parts that are required to be replaced or repaired during the course of a medical procedure.
Application Insights:
The market is segmented by application into hospitals, ambulatory care centers, home care and others. The hospital segment dominated the global market in 2017 owing to an increase in the prevalence of chronic diseases such as asthma, COPD and bronchospasm. According to a study published by WHO in 2016, it was estimated that around 1 billion people suffer from chronic bronchitis globally. Thus increasing number of patients suffering from COPD or other lung diseases are driving demand for pulmonary devices in hospitals across the world.
On the other hand, home care is expected to be fastest-growing application over forecast period due to growing awareness about availability of advanced therapies at affordable costs rather than visiting a hospital frequently for treatment which can prove costly both financially as well as emotionally draining on patients¢â‚¬â„¢ end thus resulting in high adoption of these devices through various forms such as inhalers.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness regarding treatment options are some factors driving the growth of this regional market. In addition, growing prevalence of chronic diseases such as COPD is also expected to boost demand for pulmonary devices during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising healthcare expenditure by governments and private organizations in order to improve patient care standards and infrastructure development in emerging countries such as China & India is expected drive growth over next eight years.
Growth Factors:
- Increasing incidence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for pulmonary devices in the coming years.
- Technological advancements: The development of innovative and advanced devices is helping to improve the diagnosis and treatment of respiratory disorders. This is propelling the growth of the pulmonary devices market worldwide.
- Growing awareness about respiratory health: There has been a growing awareness among people about proper breathing techniques and methods for preventing respiratory problems. This is aiding in driving demand for pulmonary devices across regions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pulmonary Devices Market Research Report
By Type
Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, Monitoring Devices
By Application
Hospitals, Ambulatory Care, Home Care
By Companies
GLAXOSMITHKLINE PLC, 3M COMPANY, MEDTRONIC PLC, KONINKLIJKE PHILIPS N.V., RESMED INC., MASIMO CORPORATION, THERMO FISHER SCIENTIFIC, FISHER & PAYKEL HEALTHCARE LIMITED, BECTON, DICKINSON AND COMPANY, HAMILTON MEDICAL AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pulmonary Devices Market Report Segments:
The global Pulmonary Devices market is segmented on the basis of:
Types
Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, Monitoring Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Care, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GLAXOSMITHKLINE PLC
- 3M COMPANY
- MEDTRONIC PLC
- KONINKLIJKE PHILIPS N.V.
- RESMED INC.
- MASIMO CORPORATION
- THERMO FISHER SCIENTIFIC
- FISHER & PAYKEL HEALTHCARE LIMITED
- BECTON, DICKINSON AND COMPANY
- HAMILTON MEDICAL AG
Highlights of The Pulmonary Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Therapeutic Devices
- Consumables and Accessories
- Diagnostic Devices
- Monitoring Devices
- By Application:
- Hospitals
- Ambulatory Care
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pulmonary Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pulmonary devices are medical devices that are inserted into the airways of the lungs to help improve breathing. Pulmonary devices can include a variety of different types of masks, tubes, and pumps.
Some of the major companies in the pulmonary devices market are GLAXOSMITHKLINE PLC, 3M COMPANY, MEDTRONIC PLC, KONINKLIJKE PHILIPS N.V., RESMED INC., MASIMO CORPORATION, THERMO FISHER SCIENTIFIC, FISHER & PAYKEL HEALTHCARE LIMITED, BECTON, DICKINSON AND COMPANY, HAMILTON MEDICAL AG.
The pulmonary devices market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pulmonary Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pulmonary Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pulmonary Devices Market - Supply Chain
4.5. Global Pulmonary Devices Market Forecast
4.5.1. Pulmonary Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pulmonary Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pulmonary Devices Market Absolute $ Opportunity
5. Global Pulmonary Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pulmonary Devices Market Size and Volume Forecast by Type
5.3.1. Therapeutic Devices
5.3.2. Consumables and Accessories
5.3.3. Diagnostic Devices
5.3.4. Monitoring Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pulmonary Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pulmonary Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Care
6.3.3. Home Care
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pulmonary Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pulmonary Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pulmonary Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pulmonary Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pulmonary Devices Demand Share Forecast, 2019-2026
9. North America Pulmonary Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pulmonary Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pulmonary Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Care
9.4.3. Home Care
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pulmonary Devices Market Size and Volume Forecast by Type
9.7.1. Therapeutic Devices
9.7.2. Consumables and Accessories
9.7.3. Diagnostic Devices
9.7.4. Monitoring Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pulmonary Devices Demand Share Forecast, 2019-2026
10. Latin America Pulmonary Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pulmonary Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pulmonary Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Care
10.4.3. Home Care
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pulmonary Devices Market Size and Volume Forecast by Type
10.7.1. Therapeutic Devices
10.7.2. Consumables and Accessories
10.7.3. Diagnostic Devices
10.7.4. Monitoring Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pulmonary Devices Demand Share Forecast, 2019-2026
11. Europe Pulmonary Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pulmonary Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pulmonary Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Care
11.4.3. Home Care
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pulmonary Devices Market Size and Volume Forecast by Type
11.7.1. Therapeutic Devices
11.7.2. Consumables and Accessories
11.7.3. Diagnostic Devices
11.7.4. Monitoring Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by ype
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pulmonary Devices Demand Share, 2019-2026
12. Asia Pacific Pulmonary Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pulmonary Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pulmonary Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Care
12.4.3. Home Care
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pulmonary Devices Market Size and Volume Forecast by Type
12.7.1. Therapeutic Devices
12.7.2. Consumables and Accessories
12.7.3. Diagnostic Devices
12.7.4. Monitoring Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pulmonary Devices Demand Share, 2019-2026
13. Middle East & Africa Pulmonary Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pulmonary Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pulmonary Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Care
13.4.3. Home Care
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pulmonary Devices Market Size and Volume Forecast by Type
13.7.1. Therapeutic Devices
13.7.2. Consumables and Accessories
13.7.3. Diagnostic Devices
13.7.4. Monitoring Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pulmonary Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pulmonary Devices Market: Market Share Analysis
14.2. Pulmonary Devices Distributors and Customers
14.3. Pulmonary Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GLAXOSMITHKLINE PLC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. 3M COMPANY
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MEDTRONIC PLC
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. KONINKLIJKE PHILIPS N.V.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. RESMED INC.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MASIMO CORPORATION
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. THERMO FISHER SCIENTIFIC
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. FISHER & PAYKEL HEALTHCARE LIMITED
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BECTON, DICKINSON AND COMPANY
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. HAMILTON MEDICAL AG
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
